Subscriber, you're going to miss this ⏰

The Oxford Club Special Opportunities SPECIAL OPPORTUNITIES [The Oxford Club Special Opportunities]( Subscriber, You're Going To Miss This ⏰ Rachel Gearhart | Publisher | The Oxford Club [Rachel Gearhart] Subscriber, We emailed you a couple days ago about an [urgent opportunity](. And it's grown even moreurgent since then. In fact, you need to see this [TODAY](. A $10 biotech company has harnessed the power of AI to reinvent how cures and treatments are developed. Slashing costs and development time in the process. Nvidia is so blown away that they've made this unknown $10 firm one of their TOP investments... ahead of a big announcement[that could literally come as soon as at any minute now](. How big? This announcement could upend the $11 trillion healthcare, life sciences, and pharma industries. This company's breakthrough is so innovative that a top pharma exec recently declared it, "...could be one of the most disruptive technologies of our time." Yet I doubt 1 in 1,000 investors even knows it exists. Which is why Chief Income Strategist Marc Lichtenfeld - America's leading stock catalyst expert - sat down for a special one-on-one interview just ahead of the big news. [WATCH IT NOW]( while there's still time. It's your last chance. Good investing, Rachel [The Oxford Club] You are receiving this email as a part of your membership in The Oxford Club. Oxford Club Special Opportunities is published by The Oxford Club. To unsubscribe from opportunity based emails like this one, [click here](. Please note that this will not impact the fulfillment of your subscription in any way.. Questions? Check out our [FAQs](. Trying to reach us? [Contact us here.]( Please do not reply to this email as it goes to an unmonitored inbox. [Privacy Policy]( | [Whitelist The Oxford Club Special Opportunities]( © 2024 The Oxford Club, LLC All Rights Reserved The Oxford Club | [105 West Monument Street](#) | [Baltimore, MD 21201](#) North America: [1.800.589.3430](#) | International: [+1.443.353.4334](#) | Fax: [1.410.329.1923](#) [Oxfordclub.com]( Nothing published by The Oxford Club should be considered personalized investment advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed personalized investment advice. We allow the editors of our publications to recommend securities that they own themselves. However, our policy prohibits editors from exiting a personal trade while the recommendation to subscribers is open. In no circumstance may an editor sell a security before subscribers have a fair opportunity to exit. The length of time an editor must wait after subscribers have been advised to exit a play depends on the type of publication. All other employees and agents must wait 24 hours after publication before trading on a recommendation. Any investments recommended by The Oxford Club should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company. Protected by copyright laws of the United States and international treaties. The information found on this website may only be used pursuant to the membership or subscription agreement and any reproduction, copying or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of The Oxford Club, LLC, 105 West Monument Street, Baltimore, MD 21201.